Reclassifying patients with early-stage Hodgkin lymphoma based on functional radiographic markers at presentation

The presence of bulky disease in Hodgkin lymphoma (HL), traditionally defined with a 1-dimensional measurement, can change a patient’s risk grouping and thus the treatment approach. We hypothesized that 3-dimensional measurements of disease burden obtained from baseline (18)F-fluorodeoxyglucose posi...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Blood
Главные авторы: Akhtari, Mani, Milgrom, Sarah A., Pinnix, Chelsea C., Reddy, Jay P., Dong, Wenli, Smith, Grace L., Mawlawi, Osama, Abou Yehia, Zeinab, Gunther, Jillian, Osborne, Eleanor M., Andraos, Therese Y., Wogan, Christine F., Rohren, Eric, Garg, Naveen, Chuang, Hubert, Khoury, Joseph D., Oki, Yasuhiro, Fanale, Michelle, Dabaja, Bouthaina S.
Формат: Artigo
Язык:Inglês
Опубликовано: American Society of Hematology 2018
Предметы:
Clinical Trials and Observations
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5755043/
https://ncbi.nlm.nih.gov/pubmed/29038339
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2017-04-773838
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы